The latest information on the Johnson & Johnson COVID-19 vaccine

Dr. Jen Ashton breaks down the numbers behind some rare clotting incidents.
2:06 | 04/15/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:



Skip to this video now

Now Playing:


Related Extras
Related Videos
Video Transcript
Transcript for The latest information on the Johnson & Johnson COVID-19 vaccine
Dr. Ashton here with us, as always, to walk us through what's going on with certainly some updates, a lot of vaccine talk this week, but let's get the numbers first that we get from Johns Hopkins university, now more than 138.3 million cases of coronavirus confirmed worldwide, death toll here, cannot believe this number, I can't imagine we would get to, we're talking about 564,000 plus American lives lost to this virus. Vaccination numbers on the rise as well, CDC now reporting we're closing in on 123 million adults receiving at least one dose of that vaccine. Yep, and that's 48%. Nearly 48% of Americans here in the United States, which is pretty incredible. American adults. I keep having to qualify that. Friday eve, everybody. Yesterday, the CDC held that hearing on the j&j vaccine, we got some information but we didn't get a decision as to whether or not they're going to make that pause permanent or lift it. What did we learn? They're being very cautious, but they released some clinical information. So let's take a closer look, because this information is interesting. All six of these cases of rare blood clots so far have occurred in women who are white, one out of six of those women were on hormones, they were taking estrogen and progesterone, which can also increase clotting risk. Half of them were obese. But none had a history of clotting disorders. And I think what's important to remember, their symptoms, five out of six of them had initial early symptoms of headache, later that progressed, four out of six of them had neurologic findings like arm weakness, difficulty speaking indicating a clot in the brain. No change in lifting the pause but still some requisite -- something came out of this about recommendations for the public. Absolutely. For the public and for health care providers, they are suggesting that anyone who has gotten the j&j vaccine in the last three weeks be on the lookout for certain signs and symptoms of severe headache, abdominal pain, leg pain. If you develop those symptoms, you should seek medical attention, and absolutely tell them that you had the j&j vaccine. All right. Dr. Ashton, thank you. We'll continue to follow that. We appreciate it.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:06","description":"Dr. Jen Ashton breaks down the numbers behind some rare clotting incidents.","mediaType":"default","section":"ABCNews/GMA","id":"77093611","title":"The latest information on the Johnson & Johnson COVID-19 vaccine","url":"/GMA/GMA3/video/latest-information-johnson-johnson-covid-19-vaccine-77093611"}